Spebrutinib
Product Specifications
CAS Number
1202757-89-8
Target
BTK, Src
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis
Purity
>99.99%
Bioactivity
Spebrutinib (LMK-435) is an orally bioavailable, selective inhibitor of Bruton's agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity.
Smiles
COCCOc1ccc(Nc2ncc(F)c(Nc3cccc(NC(=O)C=C)c3)n2)cc1
Molecular Formula
C22H22FN5O3
Molecular Weight
423.44
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
56557121 3x 1.0µg DNA
DKKL2 CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details 
LV658423 1.0 µg DNA
SYCP1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details IJD83200-01 100 mg
[3,5-Dimethyl-1- (2-methylphenyl) -1H-pyrazol-4-yl]methanamine dihydrochloride
Sign In for Pricing
View Details IJD83200-02 1 g
[3,5-Dimethyl-1- (2-methylphenyl) -1H-pyrazol-4-yl]methanamine dihydrochloride
Sign In for Pricing
View Details